AnalystsAnanda GhoshAnanda Ghosh's Stock Forecasts
AnalystsAnanda Ghosh
Sectors:
Industries:
Analyst Ranking
Bottom 11%
#4750 out of 5271 analysts
Average Return
-4.31%
Win Rate
30%7 out of 23
Risk vs Reward
Poor
Good
Ananda Ghosh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | +141.67% | $16.20 | $39.15 | 2025-08-06 - 2026-05-07 | Buy |
Annexon IncANNX | +126.23% | $2.44 | $5.52 | 2025-08-14 - 2026-05-07 | Buy |
Avidity Biosciences IncRNAM | +56.46% | $44.74 | $70.00 | 2025-09-11 - 2025-10-27 | Buy |
Maze Therapeutics IncMAZE | +44.39% | $17.64 | $25.47 | 2025-07-22 - 2026-05-07 | Buy |
Dyne Therapeutics IncDYN | +20.14% | $14.60 | $17.54 | 2026-03-02 - 2026-05-07 | Buy |
Ananda Ghosh Analyst Color
Get additional color on Ananda Ghosh's coverage of popular stocks
Ananda Ghosh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Maze Therapeutics IncMAZE | 5 | Buy | $110.00 | +331.88% | Maintains | a month ago |
Structure Therapeutics IncGPCR | 4 | Buy | $100.00 | +155.43% | Maintains | 2 months ago |
Dyne Therapeutics IncDYN | 3 | Buy | $50.00 | +185.06% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $37.00 | +64.01% | Reiterates | 3 months ago |
Stoke Therapeutics IncSTOK | 1 | Buy | $50.00 | +52.49% | Maintains | 5 months ago |
Pepgen IncPEPG | 3 | Buy | $20.00 | +1,017.32% | Maintains | 6 months ago |
Avidity Biosciences IncRNAM | 2 | Hold | $72.00 | +388.14% | Downgrades | 6 months ago |
Inventiva SaIVA | 2 | Buy | $24.00 | +348.60% | Maintains | 7 months ago |
Skye Bioscience IncSKYE | 1 | Buy | $20.00 | +2,127.17% | Initiates Coverage On | 7 months ago |
Annexon IncANNX | 1 | Buy | $14.00 | +153.62% | Reiterates | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.